Loading…
Reporting person on SEC Form 4
Nancy A. Grygiel
SVP & CCO
Disclosures on record
21
Companies involved
1
Disclosure history
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
Officer sold
~$506KReported value · 1,500 sh @ $337.2625
Stock since the trade +21.2% · S&P 500 +17.1% · to Oct 1
Amgen's SVP & CCO sold $506K of Amgen shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.